Back

Jerome KELDENICH

Founder

Biography: With more than 20 years of experience in Pharmaceutical Development spent in C(D)MOs, Biotech and Large Pharmaceutical Companies, Dr. Jerome Keldenich, PhD, has developed a profound interest in the application of Quality Risk Management and Quality by Design principles to the development of Drug Products. This interest has been translated in specific tools used to capturing the knowledge acquired during the development drug products in all the classical and less classical dosage forms (from Oral Solid Dosage forms to Injectables). These tools are aligned with current ICH Q8, Q9, Q10, Q12 and Q13 ICH guidelines in particular for Lyophilized Drug Products.

Panel Discussion Embracing innovation: towards a new paradigm for Freeze-drying

06/05/2025 | 14:30 - 14:45 | TPD Room